Inhibrx (INBX) Short Interest Ratio & Short Volume → Central Bank Gold Heist In Progress (From Colonial Metals) (Ad) Free INBX Stock Alerts $34.94 -0.06 (-0.17%) (As of 03/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Inhibrx Short Interest DataCurrent Short Volume1,950,000 sharesPrevious Short Volume2,100,000 sharesChange Vs. Previous Month-7.14%Dollar Volume Sold Short$71.43 millionShort Interest Ratio / Days to Cover2.6Last Record DateFebruary 29, 2024Outstanding Shares47,390,000 sharesFloat Size35,590,000 sharesShort Percent of Float5.48%Today's Trading Volume539,707 sharesAverage Trading Volume627,826 sharesToday's Volume Vs. Average86% Short Selling Inhibrx ? Sign up to receive the latest short interest report for Inhibrx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINBX Short Interest Over TimeINBX Days to Cover Over TimeINBX Percentage of Float Shorted Over Time Ad Banyan Hill PublishingAI Cracks Open Largest Untapped Energy Reserve on EarthThis orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… ]click here to watch a free presentation where I reveal all the details of this lucrative opportunit Inhibrx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/20241,950,000 shares $71.43 million -7.1%5.5%2.6 $36.63 2/15/20242,100,000 shares $79.78 million -12.5%5.9%3 $37.99 1/31/20242,400,000 shares $92.47 million -41.3%6.7%3.4 $38.53 1/15/20244,090,000 shares $142.74 million +20.3%11.5%6.1 $34.90 12/31/20233,400,000 shares $129.20 million -6.1%9.6%7.4 $38.00 12/15/20233,620,000 shares $101.83 million -30.1%10.2%8.9 $28.13 Get the Latest News and Ratings for INBX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibrx and its competitors with MarketBeat's FREE daily newsletter. 11/30/20235,180,000 shares $107.59 million -2.1%15.0%12 $20.77 11/15/20235,290,000 shares $107.23 million +5.4%15.3%12 $20.27 10/31/20235,020,000 shares $77.66 million +1.0%15.0%11.2 $15.47 10/15/20234,970,000 shares $87.97 million -7.1%14.9%10.5 $17.70 9/30/20235,350,000 shares $98.17 million +11.2%16.0%11.9 $18.35 9/15/20234,810,000 shares $100.58 million -5.5%14.4%11.3 $20.91 8/31/20235,090,000 shares $108.93 million -12.8%15.3%12.8 $21.40 8/15/20235,840,000 shares $99.69 million +1.7%17.5%15.7 $17.07 7/31/20235,740,000 shares $115.09 million +0.9%18.0%16.4 $20.05 7/15/20235,690,000 shares $138.32 million -1.4%17.9%17 $24.31 6/30/20235,770,000 shares $149.79 million -4.0%18.2%16 $25.96 6/15/20236,010,000 shares $167.20 million +1.0%20.4%15.8 $27.82 5/31/20235,950,000 shares $140.78 million +3.3%20.2%15.4 $23.66 5/15/20235,760,000 shares $144.86 million +0.4%19.6%13.8 $25.15 4/30/20235,740,000 shares $120.54 million -2.1%19.5%14.1 $21.00 4/15/20235,860,000 shares $106.95 million -0.3%19.9%15.1 $18.25 3/31/20235,880,000 shares $110.96 million -3.0%20.0%14.5 $18.87 3/15/20236,060,000 shares $136.71 million +7.8%20.6%14.4 $22.56 2/28/20235,620,000 shares $135.22 million +8.5%19.1%12.9 $24.06 2/15/20235,180,000 shares $120.90 million -1.7%17.6%12.3 $23.34 1/31/20235,270,000 shares $131.75 million -3.0%19.1%11.7 $25.00 1/15/20235,430,000 shares $128.47 million +26.3%18.1%11.3 $23.66 12/30/20224,300,000 shares $105.95 million +8.6%14.4%8.5 $24.64 12/15/20223,960,000 shares $110.96 million -10.8%13.2%5.4 $28.02 11/30/20224,440,000 shares $133.11 million -1.1%15.7%5.7 $29.98 11/15/20224,490,000 shares $146.82 million -2.8%15.9%5.8 $32.70 10/31/20224,620,000 shares $148.67 million +16.7%18.0%6.2 $32.18 10/15/20223,960,000 shares $118.21 million -4.1%15.5%5.5 $29.85 9/30/20224,130,000 shares $74.13 million +25.5%16.2%5.9 $17.95 9/15/20223,290,000 shares $48.66 million +0.6%12.9%6.9 $14.79 8/31/20223,270,000 shares $58.01 million +0.3%12.8%7.2 $17.74 8/15/20223,260,000 shares $80.46 million -13.3%12.8%7.5 $24.68 7/31/20223,760,000 shares $65.20 million +5.3%14.4%7.7 $17.34 7/15/20223,570,000 shares $61.69 million +15.2%13.7%7.2 $17.28Make This $3 Trade the Instant the Opening Bell Rings (Ad)Since the birth of Wall Street, one simple rule has remained the same.... Buy stocks that are cheap....When they’re on sale…. And when nobody else is looking…See Why This $3.00 Stock Could Hit $15.00 INBX Short Interest - Frequently Asked Questions What is Inhibrx's current short interest? Short interest is the volume of Inhibrx shares that have been sold short but have not yet been covered or closed out. As of February 29th, investors have sold 1,950,000 shares of INBX short. 5.48% of Inhibrx's shares are currently sold short. Learn More on Inhibrx's current short interest. What is a good short interest ratio for Inhibrx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INBX shares currently have a short interest ratio of 3.0. Learn More on Inhibrx's short interest ratio. Which institutional investors are shorting Inhibrx? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Inhibrx: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Inhibrx? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.48% of Inhibrx's floating shares are currently sold short. Is Inhibrx's short interest increasing or decreasing? Inhibrx saw a drop in short interest in the month of February. As of February 29th, there was short interest totaling 1,950,000 shares, a drop of 7.1% from the previous total of 2,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Inhibrx's float size? Inhibrx currently has issued a total of 47,390,000 shares. Some of Inhibrx's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Inhibrx currently has a public float of 35,590,000 shares. How does Inhibrx's short interest compare to its competitors? 5.48% of Inhibrx's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Inhibrx: Adaptimmune Therapeutics plc (0.28%), 4D Molecular Therapeutics, Inc. (16.75%), ADMA Biologics, Inc. (2.94%), Twist Bioscience Co. (21.45%), Sana Biotechnology, Inc. (17.85%), Autolus Therapeutics plc (1.19%), Relay Therapeutics, Inc. (8.39%), CARGO Therapeutics, Inc. (8.46%), Scholar Rock Holding Co. (15.49%), Vericel Co. (4.70%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short Inhibrx stock? Short selling INBX is an investing strategy that aims to generate trading profit from Inhibrx as its price is falling. INBX shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Inhibrx? A short squeeze for Inhibrx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INBX, which in turn drives the price of the stock up even further. How often is Inhibrx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INBX, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: ADAP Short Squeeze FDMT Short Squeeze ADMA Short Squeeze TWST Short Squeeze SANA Short Squeeze AUTL Short Squeeze RLAY Short Squeeze CRGX Short Squeeze SRRK Short Squeeze VCEL Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INBX) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThe world’s greatest investmentPorter & CompanySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBitcoin dollar warningStansberry ResearchThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy